Healthcare provider profile · identity verified

Jerry A Lambert, MD

Allopathic & Osteopathic Physicians|Family Medicine · NORTH AUGUSTA, SC · NPI 1053351999

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Jerry A Lambert, MD received $124.85 in general payments during 2025 across 3 reported records.

ABIOMED accounted for 72.3% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 3 associated products.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$124.85

3 reported records · 3 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
ABIOMED	Unresolved — no canonical attribution shown	$90.30	72.3%	1	2025
Exact Sciences Corporation	Unresolved — no canonical attribution shown	$18.23	14.6%	1	2025
Merck Sharp & Dohme LLC	Unresolved — no canonical attribution shown	$16.32	13.1%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$124.85	3

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
Cologuard Collection Kit Normalized: cologuard collection kit	Device	Exact Sciences Corporation	$18.23	1	2025
Source payment records 2025-02-19 · Exact Sciences Corporation · $18.23 · Open Payments source
CAPVAXIVE Normalized: capvaxive	Biological	Merck Sharp & Dohme LLC	$16.32	1	2025
Source payment records 2025-05-13 · Merck Sharp & Dohme LLC · $16.32 · Open Payments source
GARDASIL 9 Normalized: gardasil 9	Biological	Merck Sharp & Dohme LLC	$16.32	1	2025
Source payment records 2025-05-13 · Merck Sharp & Dohme LLC · $16.32 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	498	160
Levothyroxine Sodium	Levothyroxine Sodium	405	109
Atorvastatin Calcium	Atorvastatin Calcium	372	119
Rosuvastatin Calcium	Rosuvastatin Calcium	367	115
Lisinopril	Lisinopril	299	91
Alprazolam	Alprazolam	278	57
Metformin Hcl	Metformin Hcl	261	86
Allopurinol	Allopurinol	230	59
Omeprazole	Omeprazole	220	74
Mounjaro	Tirzepatide	206	40
Pantoprazole Sodium	Pantoprazole Sodium	206	71
Tramadol Hcl	Tramadol Hcl	178	45
Gabapentin	Gabapentin	173	50
Simvastatin	Simvastatin	170	52
Fluticasone Propionate	Fluticasone Propionate	167	66
Eliquis	Apixaban	166	40
Losartan Potassium	Losartan Potassium	164	52
Famotidine	Famotidine	161	58
Duloxetine Hcl	Duloxetine Hcl	147	44
Clonazepam	Clonazepam	145	25
Metoprolol Succinate	Metoprolol Succinate	144	44
Hydrochlorothiazide	Hydrochlorothiazide	143	51
Furosemide	Furosemide	142	53
Tamsulosin Hcl	Tamsulosin Hcl	139	43
Lorazepam	Lorazepam	123	17
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	115	40
Montelukast Sodium	Montelukast Sodium	112	35
Escitalopram Oxalate	Escitalopram Oxalate	108	34
Zolpidem Tartrate	Zolpidem Tartrate	108	15
Albuterol Sulfate Hfa	Albuterol Sulfate	103	41
Metoprolol Tartrate	Metoprolol Tartrate	103	33
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	98	85
Carvedilol	Carvedilol	98	32
Prednisone	Prednisone	98	49
Valsartan	Valsartan	98	31
Clopidogrel	Clopidogrel Bisulfate	92	31
Spironolactone	Spironolactone	92	31
Ozempic	Semaglutide	82	19
Sertraline Hcl	Sertraline Hcl	81	26
Tizanidine Hcl	Tizanidine Hcl	77	29
Diclofenac Sodium	Diclofenac Sodium	74	37
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	74	23
Olmesartan Medoxomil	Olmesartan Medoxomil	69	19
Diazepam	Diazepam	68	16
Quetiapine Fumarate	Quetiapine Fumarate	68	22
Glipizide	Glipizide	67	20
Trazodone Hcl	Trazodone Hcl	67	19
Hydralazine Hcl	Hydralazine Hcl	65	21
Zaleplon	Zaleplon	65	19
Jardiance	Empagliflozin	64	21
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	62	15
Fenofibrate	Fenofibrate	62	16
Finasteride	Finasteride	62	23
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	61	30
Atenolol	Atenolol	60	16
Donepezil Hcl	Donepezil Hcl	60	19
Pregabalin	Pregabalin	58	suppressed
Glipizide Er	Glipizide	56	18
Potassium Chloride	Potassium Chloride	56	22
Venlafaxine Hcl Er	Venlafaxine Hcl	55	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	54	14
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	54	17
Mupirocin	Mupirocin	54	18
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	54	19
Ondansetron Hcl	Ondansetron Hcl	53	25
Bupropion Xl	Bupropion Hcl	50	18
Citalopram Hbr	Citalopram Hydrobromide	50	18
Pravastatin Sodium	Pravastatin Sodium	50	18
Sildenafil Citrate	Sildenafil Citrate	49	suppressed
Testosterone Cypionate	Testosterone Cypionate	49	suppressed
Fluconazole	Fluconazole	47	30
Azithromycin	Azithromycin	46	44
Pioglitazone Hcl	Pioglitazone Hcl	45	suppressed
Oxycodone Hcl	Oxycodone Hcl	44	suppressed
Meclizine Hcl	Meclizine Hcl	43	19
Irbesartan	Irbesartan	42	12
Paroxetine Hcl	Paroxetine Hcl	42	13
Alendronate Sodium	Alendronate Sodium	40	suppressed
Doxepin Hcl	Doxepin Hcl	40	suppressed
Estradiol	Estradiol	39	14
Temazepam	Temazepam	39	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	38	13
Cephalexin	Cephalexin	38	17
Hydroxyzine Hcl	Hydroxyzine Hcl	37	15
Glyxambi	Empagliflozin/Linagliptin	36	suppressed
Ibuprofen	Ibuprofen	36	12
Azelastine Hcl	Azelastine Hcl	35	15
Vitamin D2	Ergocalciferol (Vitamin D2)	35	11
Doxycycline Hyclate	Doxycycline Hyclate	34	17
Meloxicam	Meloxicam	34	11
Lovastatin	Lovastatin	33	suppressed
Solifenacin Succinate	Solifenacin Succinate	33	suppressed
Trulicity	Dulaglutide	33	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	33	12
Promethazine Hcl	Promethazine Hcl	32	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	31	26
Triamcinolone Acetonide	Triamcinolone Acetonide	31	20
Fluoxetine Hcl	Fluoxetine Hcl	30	suppressed
Mirtazapine	Mirtazapine	30	suppressed
Aripiprazole	Aripiprazole	29	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	29	12
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	28	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	28	suppressed
Eszopiclone	Eszopiclone	27	suppressed
Synthroid	Levothyroxine Sodium	27	suppressed
Breo Ellipta	Fluticasone/Vilanterol	26	suppressed
Metformin Hcl Er	Metformin Hcl	26	suppressed
Farxiga	Dapagliflozin Propanediol	25	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	25	23
Colchicine	Colchicine	24	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	24	suppressed
Entresto	Sacubitril/Valsartan	24	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	24	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	23	suppressed
Ezetimibe	Ezetimibe	23	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	23	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	22	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	22	15
Levofloxacin	Levofloxacin	22	18
Propranolol Hcl	Propranolol Hcl	21	suppressed
Clobetasol Propionate	Clobetasol Propionate	20	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	20	14
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	20	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	19	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	18	suppressed
Ramipril	Ramipril	17	suppressed
Soliqua 100-33	Insulin Glargine/Lixisenatide	17	suppressed
Hydrocortisone	Hydrocortisone	16	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	16	suppressed
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	15	suppressed
Benazepril Hcl	Benazepril Hcl	15	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	15	suppressed
Humalog Kwikpen U-100	Insulin Lispro	15	suppressed
Olanzapine	Olanzapine	15	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	14	suppressed
Carisoprodol	Carisoprodol	14	suppressed
Celecoxib	Celecoxib	14	suppressed
Clonidine Hcl	Clonidine Hcl	14	suppressed
Indapamide	Indapamide	14	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	14	suppressed
Naproxen	Naproxen	14	suppressed
Ropinirole Hcl	Ropinirole Hcl	14	suppressed
Buspirone Hcl	Buspirone Hcl	13	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	13	suppressed
Digoxin	Digoxin	13	suppressed
Januvia	Sitagliptin Phosphate	13	suppressed
Megestrol Acetate	Megestrol Acetate	13	suppressed
Premarin	Estrogens, Conjugated	13	suppressed
Verapamil Er	Verapamil Hcl	13	suppressed
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	12	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	12	suppressed
Oxycontin	Oxycodone Hcl	12	suppressed
Spiriva Respimat	Tiotropium Bromide	12	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	12	suppressed
Topiramate	Topiramate	12	suppressed
Chlorthalidone	Chlorthalidone	11	suppressed
Jantoven	Warfarin Sodium	11	suppressed
Memantine Hcl Er	Memantine Hcl	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Nifedipine Er	Nifedipine	11	suppressed
Primidone	Primidone	11	suppressed
Ranolazine Er	Ranolazine	11	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Wegovy	Semaglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$124.85 · 3 records	ABIOMED	CAPVAXIVE, Cologuard Collection Kit, GARDASIL 9	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error